Medicare Enrolled

Dr. Tiffany Matragas, M.P.A.S., PA-C

Surgical Physician Assistant · Morristown, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
131 MADISON AVE, Morristown, NJ 07960
9735409700
In practice since 2007 (18 years)
NPI: 1801081716 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Matragas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Matragas? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Matragas

Dr. Tiffany Matragas is a surgical physician assistant in Morristown, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. Matragas performed 7,897 Medicare services across 246 unique beneficiaries.

Between the years covered by Open Payments, Dr. Matragas received a total of $4,304 from 24 pharmaceutical and/or device companies across 251 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in surgical physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Matragas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 0% volume in NJ $4,304 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,897
Medicare services
Top 0% in NJ for surgical physician assistant
246
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~439 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
7,600 $4 $12
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
84 $63 $125
Betamethasone steroid injection
An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate.
73 $5 $10
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
38 $55 $150
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
28 $37 $100
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
26 $10 $50
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
21 $87 $150
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
15 $44 $94
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
12 $98 $200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
98.2% medium
1.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,304
Total received (2021-2024)
Avg $1,076/year across 4 years
Top 4% in NJ for surgical physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
251
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,291 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,355
2023
$1,751
2022
$183
2021
$16

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$1,139
ABBVIE INC.
$405
ANI Pharmaceuticals, Inc.
$168
Amgen Inc.
$147
AstraZeneca Pharmaceuticals LP
$93
PFIZER INC.
$69
Phathom Pharmaceuticals, Inc.
$59
Pacira Pharmaceuticals Incorporated
$43
IDORSIA PHARMACEUTICALS US INC
$34
UCB, Inc.
$34
Aurinia Pharma U.S., Inc.
$33
Genentech USA, Inc.
$32
E.R. Squibb & Sons, L.L.C.
$30
Alexion Pharmaceuticals, Inc.
$19
Lilly USA, LLC
$18
GENZYME CORPORATION
$18
Mallinckrodt Hospital Products Inc.
$15
Top 3 companies account for 72.7% of 2024 payments
All-time payments by company (2021-2024) ›
Janssen Biotech, Inc.
$1,541
ABBVIE INC.
$1,070
ANI Pharmaceuticals, Inc.
$259
Horizon Therapeutics plc
$245
Amgen Inc.
$225
Pacira Pharmaceuticals Incorporated
$163
AstraZeneca Pharmaceuticals LP
$150
Aurinia Pharma U.S., Inc.
$79
PFIZER INC.
$69
UCB, Inc.
$65
IDORSIA PHARMACEUTICALS US INC
$61
Phathom Pharmaceuticals, Inc.
$59
Lilly USA, LLC
$48
Alexion Pharmaceuticals, Inc.
$33
Bayer HealthCare Pharmaceuticals Inc.
$32
Genentech USA, Inc.
$32
Collegium Pharmaceutical, Inc.
$31
E.R. Squibb & Sons, L.L.C.
$30
Mallinckrodt Hospital Products Inc.
$28
Exeltis, USA Inc.
$25
GENZYME CORPORATION
$18
Allergan, Inc.
$16
Sobi, Inc
$14
Celltrion USA Inc.
$13
Top 3 companies account for 66.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Adempas · Belbuca · Cimzia · EVENITY · Enbrel · Iovera · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · NATRELLE SALINE-FILLED BREAST IMPLANTS · ORENCIA · PURIFIED CORTROPHIN GEL · QULIPTA · QUVIVIQ · RINVOQ · SAPHNELO · SIMPONI ARIA · SKYRIZI · STRENSIQ · TALTZ · TEPEZZA · TREMFYA · VOQUEZNA · XELJANZ · YUFLYMA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for surgical physician assistant in NJ.

Looking for a surgical physician assistant in Morristown?
Compare surgical physician assistants in the Morristown area by procedure volume, costs, and industry payment transparency.
Browse surgical physician assistants nearby

Geographic Context

Surgical physician assistants within 10 mi
248
Per 100K population
48.6
County median income
$134,929
Nearest hospital
GREYSTONE PARK PSYCHIATRIC HOSPITAL
4.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Matragas is a mixed practice specialist, with above-average Medicare volume (top 0% in NJ), with low-engagement industry engagement in the top 4% of NJ peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Matragas experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Matragas performed 7,600 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Matragas receive payments from pharmaceutical companies?
Yes. Dr. Matragas received a total of $4,304 from 24 companies across 251 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Matragas's costs compare to other surgical physician assistants in Morristown?
Dr. Matragas's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Matragas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →